Skip to main content

Eversept Partners, LP

SEC CIK
0001697013
Latest filing
Aug 14, 2026

Holdings in Q1 2022

Holdings as of Mar 31, 2022, filed Nov 8, 2023. Long positions only; changes compare share counts with Q4 2021.

Institution overview
Positions
76
−14 vs. Q4 2021
Portfolio value
$1.09B
−$115.0M (−9.6%) vs. Q4 2021
Filed
Nov 8, 2023
AmendedSEC
Holdings of Eversept Partners, LP in Q1 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
CYHCommunity Health Systems IncCOM7,126,711$84.6M7.8%+737,173+11.5%AddedHistory
BHVNBiohaven Ltd.COM644,666$76.4M7.0%+329,537+104.6%AddedHistory
HZNPHorizon Therapeutics Public Ltd CoSHS609,939$64.2M5.9%−223,811−26.8%ReducedHistory
GSKGSK plcSPONSORED ADR1,259,162$55.5M5.1%+691,957+122.0%AddedHistory
UTHRUnited Therapeutics CorpCOM292,234$52.4M4.8%−99,686−25.4%ReducedHistory
AZNAstraZeneca PLCSPONSORED ADR745,263$49.4M4.6%−203,961−21.5%ReducedHistory
ASNDAscendis Pharma A/SSPONSORED ADR417,172$49.0M4.5%+13,494+3.3%AddedHistory
DHRDanaher CorpStock159,768$46.9M4.3%−10,285−6.0%ReducedHistory
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS4,143,602$38.9M3.6%+1,842,104+80.0%AddedHistory
RCMR1 RCM Holdco Inc.COM1,361,506$36.4M3.4%+628,374+85.7%AddedHistory
AVTRAvantor, Inc.COM995,232$33.7M3.1%−130,233−11.6%ReducedHistory
MASIMasimo CorpCOM208,970$30.4M2.8%+208,970NewHistory
AMRNAmarin Corp PLCSPONS ADR NEW8,980,145$29.5M2.7%−1,593,157−15.1%ReducedHistory
HCAHCA Healthcare, Inc.COM111,440$27.9M2.6%+62,346+127.0%AddedHistory
NVSTEnvista Holdings CorpCOM569,351$27.7M2.6%−279,947−33.0%ReducedHistory
AMRXAmneal Pharmaceuticals, Inc.COM STK CL A5,491,497$22.9M2.1%−949,075−14.7%ReducedHistory
CLDXCelldex Therapeutics, Inc.COM NEW636,453$21.7M2.0%+43,975+7.4%AddedHistory
ARK ETF Tr00214Q302GENOMIC REV ETF470,506$21.6M2.0%−193,978−29.2%Reduced–
FATEFate Therapeutics IncCOM456,059$17.7M1.6%+201,269+79.0%AddedHistory
BIIBBiogen Inc.COM78,003$16.4M1.5%+44,962+136.1%AddedHistory
MCKMcKesson CorpStock52,375$16.1M1.5%−83,736−61.5%ReducedHistory
ELVElevance Health, Inc.Stock32,451$15.9M1.5%−1,843−5.4%ReducedHistory
DXCMDexcom IncCOM28,404$14.5M1.3%+22,003+343.7%AddedHistory
GHGuardant Health, Inc.COM213,203$14.1M1.3%+112,869+112.5%AddedHistory
IQVIQVIA Holdings Inc.Stock59,570$13.8M1.3%+34,952+142.0%AddedHistory
ILMNIllumina, Inc.COM38,759$13.5M1.2%+38,759NewHistory
XENEXenon Pharmaceuticals Inc.COM410,021$12.5M1.2%+200,502+95.7%AddedHistory
ICLRIcon PLCCOM46,816$11.4M1.0%−5,051−9.7%ReducedHistory
CNCCentene CorpStock119,170$10.0M0.9%−105,443−46.9%ReducedHistory
LHLabcorp Holdings Inc.COM NEW37,910$10.0M0.9%−7,612−16.7%ReducedHistory
LQDALiquidia CorpCOM NEW1,377,490$9.89M0.9%−70,408−4.9%ReducedHistory
NSTGNS Wind Down Co., Inc.COM280,695$9.75M0.9%+15,000+5.6%AddedHistory
HQYHealthequity, Inc.COM144,140$9.72M0.9%−189,212−56.8%ReducedHistory
Taro Pharmaceutical Inds LtdM8737E108SHS220,286$9.53M0.9%+39,135+21.6%Added–
QGENQiagen N.V.SHS NEW192,699$9.44M0.9%+30,165+18.6%AddedHistory
ALNYAlnylam Pharmaceuticals, Inc.COM52,871$8.63M0.8%−17,369−24.7%ReducedHistory
OCDXOrtho Clinical Diagnostics Holdings plcORD SHS445,059$8.30M0.8%−441,081−49.8%ReducedHistory
ARGXArgenx SESPONSORED ADR23,142$7.30M0.7%+1,646+7.7%AddedHistory
RGENRepligen CorpCOM36,521$6.87M0.6%+31,937+696.7%AddedHistory
SYNHSyneos Health, Inc.CL A81,416$6.59M0.6%−4,196−4.9%ReducedHistory
IONSIonis Pharmaceuticals IncCOM158,806$5.88M0.5%−225,983−58.7%ReducedHistory
ZNTLZentalis Pharmaceuticals, Inc.COM100,187$4.62M0.4%+37,024+58.6%AddedHistory
EXELExelixis, Inc.COM203,156$4.61M0.4%−332,544−62.1%ReducedHistory
IRTCiRhythm Holdings, Inc.COM27,047$4.26M0.4%−46,122−63.0%ReducedHistory
MASS908 Devices Inc.COM217,149$4.13M0.4%+217,149NewHistory
PBYIPuma Biotechnology, Inc.COM1,424,650$4.10M0.4%+306,752+27.4%AddedHistory
GOSSGossamer Bio, Inc.COM374,723$3.25M0.3%+334,813+838.9%AddedHistory
VRDNViridian Therapeutics, Inc.COM155,743$2.88M0.3%−38,846−20.0%ReducedHistory
ANABAnaptysbio, IncCOM114,165$2.82M0.3%−68,447−37.5%ReducedHistory
Radius Health, Inc.750469207COM NEW302,172$2.67M0.2%+302,172New–
WHWKWhitehawk Therapeutics, Inc.COM150,817$2.56M0.2%+150,817NewHistory
AAgilent Technologies, Inc.COM19,255$2.55M0.2%−176−0.9%ReducedHistory
ISRGIntuitive Surgical IncCOM NEW8,163$2.46M0.2%−1,662−16.9%ReducedHistory
MRUSMerus N.V.COM76,849$2.03M0.2%+57,849+304.5%AddedHistory
KRTXKaruna Therapeutics, Inc.COM15,934$2.02M0.2%00.0%UnchangedHistory
MRKMerck & Co., Inc.Stock9,483$1.99M0.2%−9,973−51.3%ReducedHistory
RVTYRevvity, Inc.COM9,788$1.71M0.2%−21,081−68.3%ReducedHistory
AUTLAutolus Therapeutics plcSPON ADS371,540$1.55M0.1%−30,000−7.5%ReducedHistory
MISTMilestone Pharmaceuticals Inc.COM147,165$944.8K0.1%00.0%UnchangedHistory
ENSGEnsign Group, IncCOM10,397$936.4K0.1%00.0%UnchangedHistory
HSKAHeska CorpCOM RESTRC NEW5,836$807.0K0.1%+1,311+29.0%AddedHistory
KODKodiak Sciences Inc.COM91,200$704.1K0.1%+91,200NewHistory
ASMBAssembly Biosciences, Inc.COM280,000$576.8K0.1%−30,000−9.7%ReducedHistory
SPROSpero Therapeutics, Inc.COM59,639$518.9K<0.1%+59,639NewHistory
SNDASonida Senior Living, Inc.COM15,209$503.9K<0.1%00.0%UnchangedHistory
ACIUAC Immune SASHS124,589$498.4K<0.1%−28,791−18.8%ReducedHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR237,086$488.4K<0.1%−111,630−32.0%ReducedHistory
SRGASurgalign Holdings, Inc.COM1,573,802$478.9K<0.1%−344,941−18.0%ReducedHistory
TECHBIO-TECHNE CorpCOM1,062$459.9K<0.1%+1,062NewHistory
ELDNEledon Pharmaceuticals, Inc.COM114,008$449.2K<0.1%00.0%UnchangedHistory
MREOMereo BioPharma Group plcSPON ADS370,170$414.6K<0.1%+110,700+42.7%AddedHistory
KRSAKorsana Biosciences, Inc.COM371,955$412.9K<0.1%00.0%UnchangedHistory
TECXTectonic Therapeutic, Inc.COM295,369$389.9K<0.1%−9,620−3.2%ReducedHistory
ORTXOrchard Therapeutics plcADS419,581$298.7K<0.1%00.0%UnchangedHistory
CBIOCrescent Biopharma, Inc.COM100,579$114.7K<0.1%+579+0.6%AddedHistory
CLVSClovis Oncology, Inc.COM30,000$60.6K<0.1%+30,000NewHistory

Options (10)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Eversept Partners, LP in Q1 2022
SecurityClassPutsCalls
GSKGSK plcSPONSORED ADR–$67.7M
Invesco QQQ Trust Series I46090E103ETF$65.3M–
AZNAstraZeneca PLCSPONSORED ADR–$38.0M
BIIBBiogen Inc.COM–$29.5M
iShares Inc46434G772MSCI TAIWAN ETF$6.14M–
MRKMerck & Co., Inc.Stock–$4.00M
PGNYProgyny, Inc.COM$2.57M–
KODKodiak Sciences Inc.COM$1.40M–
TEVATeva Pharmaceutical Industries LtdSPONSORED ADS–$872.3K
iShares Russell 2000 Growth ETF464287648ETF$434.8K–

Sold out since Q4 2021 (23)

Positions held at the end of Q4 2021 that are gone from this filing.

Positions of Eversept Partners, LP sold out since Q4 2021
SecurityClassShares in Q4 2021Value in Q4 2021% of portfolio in Q4 2021History
HUMHumana IncStock27,382$12.7M1.1%History
ITCIIntra-Cellular Therapies, Inc.COM231,787$12.1M1.0%History
ARK Innovation ETF00214Q104ETF119,118$11.3M0.9%–
MGLNMagellan Health IncCOM NEW104,700$9.95M0.8%History
NTRANatera, Inc.COM102,071$9.53M0.8%History
ZGNXZogenix, Inc.COM NEW550,966$8.95M0.7%History
PODDInsulet CorpStock30,172$8.03M0.7%History
CERNCERNER CorpCOM77,543$7.22M0.6%History
SIBNSI-BONE, Inc.COM258,094$5.73M0.5%History
NVRONevro CorpCOM66,074$5.36M0.4%History
AUPHAurinia Pharmaceuticals Inc.COM201,384$4.61M0.4%History
MRVIMaravai Lifesciences Holdings, Inc.COM CL A87,795$3.68M0.3%History
LXRXLexicon Pharmaceuticals, Inc.COM NEW797,694$3.14M0.3%History
Curevac N VN2451R105COM85,017$2.92M0.2%–
GRTSGritstone bio, Inc.COM170,125$2.19M0.2%History
MRTXMirati Therapeutics, Inc.COM14,840$2.18M0.2%History
SNYSanofiSPONSORED ADR38,672$1.94M0.2%History
ESTAEstablishment Labs Holdings Inc.COM25,137$1.70M0.1%History
MYOMyomo, Inc.COM NEW150,000$1.03M0.1%History
VCRAVocera Communications, Inc.COM14,970$970.7K0.1%History
LogicBio Therapeutics, Inc.54142F102COM291,101$672.4K0.1%–
BKDBrookdale Senior Living Inc.COM79,146$408.4K<0.1%History
FSTXF-star Therapeutics, Inc.COM49,933$250.7K<0.1%History